![]() |
VOOZH | about |
RET PROTOONCOGENE; RET
Allelic Variants (54 Selected Examples) :
|
Number 👁 Image |
Phenotype 👁 Image |
Mutation 👁 Image |
SNP | gnomAD | ClinVar |
|---|---|---|---|---|---|
| .0001 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA | RET, CYS618GLY | rs76262710 | rs76262710 | RCV000014919... |
| .0002 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA | RET, GLU378ASP, LEU379VAL, CYS380ARG | rs267607010, rs377767408, rs75076352 | rs267607010, rs75076352 | RCV000014937... |
| .0003 |
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA
PHEOCHROMOCYTOMA, INCLUDED |
RET, CYS634GLY | rs75076352 | rs75076352 | RCV000014922... |
| .0004 |
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA
PHEOCHROMOCYTOMA, INCLUDED |
RET, CYS634TYR | rs75996173 | rs75996173 | RCV000014924... |
| .0005 |
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA
PHEOCHROMOCYTOMA, INCLUDED |
RET, CYS634SER | rs75996173 | rs75996173 | RCV000014926... |
| .0006 |
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA
THYROID CARCINOMA, FAMILIAL MEDULLARY, INCLUDED PHEOCHROMOCYTOMA, INCLUDED |
RET, CYS634PHE | rs75996173 | rs75996173 | RCV000014928... |
| .0007 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA | RET, CYS611TRP | rs80069458 | - | RCV000014932... |
| .0008 |
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA
THYROID CARCINOMA, FAMILIAL MEDULLARY, INCLUDED |
RET, CYS618SER | rs79781594 | rs79781594 | RCV000014933... |
| .0009 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA | RET, CYS620ARG | rs77316810 | - | RCV000014935... |
| .0010 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA | RET, CYS620TYR | rs77503355 | - | RCV000014936... |
| .0011 |
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA
PHEOCHROMOCYTOMA, INCLUDED |
RET, CYS634ARG | rs75076352 | rs75076352 | RCV000014937... |
| .0012 |
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA
PHEOCHROMOCYTOMA, INCLUDED |
RET, CYS634TRP | rs77709286 | rs77709286 | RCV000014939... |
| .0013 |
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB
THYROID CARCINOMA, SPORADIC MEDULLARY, INCLUDED PHEOCHROMOCYTOMA, SOMATIC, INCLUDED |
RET, MET918THR | rs74799832 | rs74799832 | RCV000014941... |
| .0014 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, 1-BP DEL, G1120 | - | - | RCV000014945 |
| .0015 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, SER765PRO | rs75075748 | - | RCV000014921 |
| .0016 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, ARG897GLN | rs76087194 | - | RCV000014946 |
| .0017 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, ARG972GLY | rs76534745 | - | RCV000014947... |
| .0018 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, SER32LEU | rs76764689 | - | RCV000014948... |
| .0019 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, PRO64LEU | rs77596424 | - | RCV000014949... |
| .0020 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, GLU136TER | rs79014735 | rs79014735 | RCV000014931 |
| .0021 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, ARG180TER | rs76449634 | - | RCV000014950... |
| .0022 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, ARG330GLN | rs80236571 | - | RCV000014951... |
| .0023 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, PHE393LEU | rs78098482 | - | RCV000014952 |
| .0024 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA | RET, CYS620PHE | rs77503355 | - | RCV000014953... |
| .0025 |
THYROID CARCINOMA, FAMILIAL MEDULLARY
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA, INCLUDED |
RET, CYS618ARG | rs76262710 | rs76262710 | RCV000014954... |
| .0026 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA, WITHOUT PHEOCHROMOCYTOMA | RET, 12-BP DUP | rs377767436 | - | RCV000014955 |
| .0027 | THYROID CARCINOMA, FAMILIAL MEDULLARY | RET, GLU768ASP | rs78014899 | rs78014899 | RCV000014956... |
| .0028 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, ARG313GLN | rs77702891 | rs77702891 | RCV000014957... |
| .0029 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA, WITH HIRSCHSPRUNG DISEASE | RET, CYS609TYR | rs77939446 | rs77939446 | RCV000014958... |
| .0030 | MOVED TO 164761.0008 | - | - | - | - |
| .0031 | MOVED TO 164761.0009 | - | - | - | - |
| .0032 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA, WITH HIRSCHSPRUNG DISEASE | RET, CYS620TRP | rs79890926 | rs79890926 | RCV000014959... |
| .0033 |
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA
THYROID CARCINOMA, FAMILIAL MEDULLARY, INCLUDED |
RET, LEU790PHE | rs75030001 | rs75030001 | RCV000014960... |
| .0034 | RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE | RET, TYR791PHE | rs77724903 | rs77724903 | RCV000014962... |
| .0035 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, ARG231HIS | rs79661516 | - | RCV000014964 |
| .0036 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, ARG982CYS | rs17158558 | rs17158558 | RCV000014965... |
| .0037 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, ILE647ILE, 1941C-T | rs75225191 | rs75225191 | RCV000014966... |
| .0038 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, ALA45ALA | rs1800858 | rs1800858 | RCV000014967... |
| .0039 | THYROID CARCINOMA, FAMILIAL MEDULLARY | RET, 9-BP DUP, EX8 | rs377767434 | - | RCV000014968 |
| .0040 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA | RET, ALA640GLY | rs78935588 | - | RCV000014969 |
| .0041 | THYROID CARCINOMA, FAMILIAL MEDULLARY | RET, CYS620SER | rs77503355 | - | RCV000014970... |
| .0042 | THYROID CARCINOMA, FAMILIAL MEDULLARY | RET, CYS609ARG | rs77558292 | - | RCV000014971... |
| .0043 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB | RET, VAL804MET, SER904CYS | rs267607011, rs79658334 | rs79658334 | RCV000148773... |
| .0044 | THYROID CARCINOMA, FAMILIAL MEDULLARY | RET, VAL804LEU | rs79658334 | rs79658334 | RCV000014973... |
| .0045 | RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE | RET, ARG114HIS | rs76397662 | rs76397662 | RCV000014974... |
| .0046 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, PRO1039LEU | rs79853121 | rs79853121 | RCV000014975... |
| .0047 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA | RET, VAL648ILE | rs77711105 | rs77711105 | RCV000014976... |
| .0048 | THYROID CARCINOMA, FAMILIAL MEDULLARY | RET, GLY533CYS | rs75873440 | rs75873440 | RCV000014977... |
| .0049 |
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA
THYROID CARCINOMA, FAMILIAL MEDULLARY, INCLUDED |
RET, SER891ALA | rs75234356 | rs75234356 | RCV000014978... |
| .0050 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, IVS1, C-T, +9.7 KB (rs2435357) | rs2435357 | rs2435357 | RCV000014980... |
| .0051 | THYROID CARCINOMA, FAMILIAL MEDULLARY | RET, ARG912PRO | rs78347871 | rs78347871 | RCV000014981... |
| .0052 | HIRSCHSPRUNG DISEASE, PROTECTION AGAINST | RET, 128496T-C | rs3026785 | rs3026785 | RCV000014982... |
| .0053 | RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE | RET, VAL778ILE | rs75686697 | rs75686697 | RCV000014983... |
| .0054 | RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE | RET, PRO198THR | rs76736111 | - | RCV000014984 |
164761
RET PROTOONCOGENE; RET
Allelic Variants (54 Selected Examples :
| Number | Phenotype | Mutation | SNP | gnomAD | ClinVar |
|---|---|---|---|---|---|
| .0001 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA | RET, CYS618GLY | rs76262710 | rs76262710 | RCV000014919, RCV000228834, RCV000522833, RCV000762807, RCV002408462, RCV002470710, RCV004760333 |
| .0002 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA | RET, GLU378ASP, LEU379VAL, CYS380ARG | rs267607010, rs377767408, rs75076352 | rs267607010, rs75076352 | RCV000014937, RCV000014938, RCV000082051, RCV000163338, RCV000196130, RCV000410079, RCV000411153, RCV000552504, RCV000677899, RCV002478712, RCV002503784, RCV003165476, RCV003460479, RCV004739308, RCV004795411 |
| .0003 |
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA
PHEOCHROMOCYTOMA, INCLUDED |
RET, CYS634GLY | rs75076352 | rs75076352 | RCV000014922, RCV000014923, RCV000182581, RCV000654584, RCV001013616, RCV001310209, RCV001420921 |
| .0004 |
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA
PHEOCHROMOCYTOMA, INCLUDED |
RET, CYS634TYR | rs75996173 | rs75996173 | RCV000014924, RCV000014925, RCV000129490, RCV000182582, RCV000425364, RCV000476408, RCV003989285, RCV004739307, RCV005394154 |
| .0005 |
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA
PHEOCHROMOCYTOMA, INCLUDED |
RET, CYS634SER | rs75996173 | rs75996173 | RCV000014926, RCV000014927, RCV000021824, RCV001262460, RCV002251730, RCV004668731 |
| .0006 |
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA
THYROID CARCINOMA, FAMILIAL MEDULLARY, INCLUDED PHEOCHROMOCYTOMA, INCLUDED |
RET, CYS634PHE | rs75996173 | rs75996173 | RCV000014928, RCV000014929, RCV000014930, RCV000471652, RCV002408463, RCV003237413 |
| .0007 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA | RET, CYS611TRP | rs80069458 | - | RCV000014932, RCV002513055 |
| .0008 |
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA
THYROID CARCINOMA, FAMILIAL MEDULLARY, INCLUDED |
RET, CYS618SER | rs79781594 | rs79781594 | RCV000014933, RCV000014934, RCV000082050, RCV000161938, RCV001013348 |
| .0009 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA | RET, CYS620ARG | rs77316810 | - | RCV000014935, RCV000182580, RCV000232285, RCV000568259, RCV000736276, RCV000826204, RCV003324711 |
| .0010 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA | RET, CYS620TYR | rs77503355 | - | RCV000014936, RCV000021801, RCV000413879, RCV000678747, RCV002408464, RCV005394155 |
| .0011 |
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA
PHEOCHROMOCYTOMA, INCLUDED |
RET, CYS634ARG | rs75076352 | rs75076352 | RCV000014937, RCV000014938, RCV000082051, RCV000163338, RCV000552504, RCV000677899, RCV003460479, RCV004739308, RCV004795411 |
| .0012 |
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA
PHEOCHROMOCYTOMA, INCLUDED |
RET, CYS634TRP | rs77709286 | rs77709286 | RCV000014939, RCV000014940, RCV000405235, RCV000459040, RCV001013621 |
| .0013 |
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB
THYROID CARCINOMA, SPORADIC MEDULLARY, INCLUDED PHEOCHROMOCYTOMA, SOMATIC, INCLUDED |
RET, MET918THR | rs74799832 | rs74799832 | RCV000014941, RCV000014942, RCV000014943, RCV000082054, RCV000161926, RCV000175096, RCV000415312, RCV000417859, RCV001292662, RCV001542764, RCV002255998, RCV004532351, RCV005394156, RCV005865181, RCV005887525 |
| .0014 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, 1-BP DEL, G1120 | - | - | RCV000014945 |
| .0015 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, SER765PRO | rs75075748 | - | RCV000014921 |
| .0016 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, ARG897GLN | rs76087194 | - | RCV000014946 |
| .0017 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, ARG972GLY | rs76534745 | - | RCV000014947, RCV005042054 |
| .0018 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, SER32LEU | rs76764689 | - | RCV000014948, RCV000678742, RCV002514098 |
| .0019 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, PRO64LEU | rs77596424 | - | RCV000014949, RCV003531901 |
| .0020 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, GLU136TER | rs79014735 | rs79014735 | RCV000014931 |
| .0021 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, ARG180TER | rs76449634 | - | RCV000014950, RCV001206325, RCV004528111 |
| .0022 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, ARG330GLN | rs80236571 | - | RCV000014951, RCV001379274, RCV004696636, RCV005394157, RCV006277647 |
| .0023 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, PHE393LEU | rs78098482 | - | RCV000014952 |
| .0024 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA | RET, CYS620PHE | rs77503355 | - | RCV000014953, RCV000233944, RCV000411165, RCV000485714, RCV002255999, RCV005394158 |
| .0025 |
THYROID CARCINOMA, FAMILIAL MEDULLARY
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA, INCLUDED |
RET, CYS618ARG | rs76262710 | rs76262710 | RCV000014954, RCV000021792, RCV000114391, RCV000345209, RCV000427260, RCV002256000 |
| .0026 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA, WITHOUT PHEOCHROMOCYTOMA | RET, 12-BP DUP | rs377767436 | - | RCV000014955 |
| .0027 | THYROID CARCINOMA, FAMILIAL MEDULLARY | RET, GLU768ASP | rs78014899 | rs78014899 | RCV000014956, RCV000021842, RCV001015022, RCV001811141, RCV002280861 |
| .0028 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, ARG313GLN | rs77702891 | rs77702891 | RCV000014957, RCV000566081, RCV000654592, RCV000662693, RCV002476968, RCV003114192 |
| .0029 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA, WITH HIRSCHSPRUNG DISEASE | RET, CYS609TYR | rs77939446 | rs77939446 | RCV000014958, RCV000082049, RCV000168107, RCV000173889, RCV000496009, RCV000509116, RCV000562113, RCV003460480, RCV004532352 |
| .0030 | MOVED TO 164761.0008 | - | - | - | - |
| .0031 | MOVED TO 164761.0009 | - | - | - | - |
| .0032 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA, WITH HIRSCHSPRUNG DISEASE | RET, CYS620TRP | rs79890926 | rs79890926 | RCV000014959, RCV000021789, RCV000566125, RCV002272020 |
| .0033 |
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA
THYROID CARCINOMA, FAMILIAL MEDULLARY, INCLUDED |
RET, LEU790PHE | rs75030001 | rs75030001 | RCV000014960, RCV000014961, RCV000021849, RCV000182583, RCV002453262 |
| .0034 | RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE | RET, TYR791PHE | rs77724903 | rs77724903 | RCV000014962, RCV000014963, RCV000034771, RCV000130367, RCV000148769, RCV000235206, RCV000312825, RCV000370653, RCV000400976, RCV000431156, RCV000436831, RCV000754613, RCV001083710, RCV005394159 |
| .0035 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, ARG231HIS | rs79661516 | - | RCV000014964 |
| .0036 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, ARG982CYS | rs17158558 | rs17158558 | RCV000014965, RCV000034774, RCV000082055, RCV000162949, RCV000202663, RCV000238890, RCV000320112, RCV000354936, RCV000410308, RCV000411820, RCV000736279, RCV001080524, RCV001269493, RCV001822995, RCV005394160 |
| .0037 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, ILE647ILE, 1941C-T | rs75225191 | rs75225191 | RCV000014966, RCV000220871, RCV000519499, RCV000988344, RCV001085461, RCV005434602 |
| .0038 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, ALA45ALA | rs1800858 | rs1800858 | RCV000014967, RCV000216697, RCV000712294, RCV001083341 |
| .0039 | THYROID CARCINOMA, FAMILIAL MEDULLARY | RET, 9-BP DUP, EX8 | rs377767434 | - | RCV000014968 |
| .0040 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA | RET, ALA640GLY | rs78935588 | - | RCV000014969 |
| .0041 | THYROID CARCINOMA, FAMILIAL MEDULLARY | RET, CYS620SER | rs77503355 | - | RCV000014970, RCV000021802, RCV000489707, RCV001013426, RCV004018626, RCV004782015 |
| .0042 | THYROID CARCINOMA, FAMILIAL MEDULLARY | RET, CYS609ARG | rs77558292 | - | RCV000014971, RCV000414355, RCV000736274, RCV001013275, RCV001851862, RCV004724742 |
| .0043 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB | RET, VAL804MET, SER904CYS | rs267607011, rs79658334 | rs79658334 | RCV000148773, RCV000182584, RCV000210181, RCV000499191, RCV000515232, RCV000586783, RCV001804750, RCV001851991, RCV002468975, RCV003153308, RCV003460494, RCV004528141, RCV004795938, RCV005865197, RCV006635423 |
| .0044 | THYROID CARCINOMA, FAMILIAL MEDULLARY | RET, VAL804LEU | rs79658334 | rs79658334 | RCV000014973, RCV000021854, RCV000354366, RCV000487450, RCV000561258, RCV000596480, RCV005394161, RCV006445467 |
| .0045 | RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE | RET, ARG114HIS | rs76397662 | rs76397662 | RCV000014974, RCV000121988, RCV000163885, RCV000198261, RCV000490359, RCV000755684, RCV001106778, RCV001106779, RCV001107412, RCV003389668, RCV004739309 |
| .0046 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, PRO1039LEU | rs79853121 | rs79853121 | RCV000014975, RCV000148783, RCV000410425, RCV000411688, RCV000563865, RCV000704911, RCV002490367, RCV003398513, RCV005089259 |
| .0047 | MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA | RET, VAL648ILE | rs77711105 | rs77711105 | RCV000014976, RCV000034767, RCV000163319, RCV000442648, RCV001082776 |
| .0048 | THYROID CARCINOMA, FAMILIAL MEDULLARY | RET, GLY533CYS | rs75873440 | rs75873440 | RCV000014977, RCV000182579, RCV000469127, RCV001012358, RCV003335040 |
| .0049 |
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA
THYROID CARCINOMA, FAMILIAL MEDULLARY, INCLUDED |
RET, SER891ALA | rs75234356 | rs75234356 | RCV000014978, RCV000014979, RCV000227193, RCV000394478, RCV000425892, RCV001016276, RCV001804732, RCV002490368, RCV003387503, RCV004566743, RCV004724743 |
| .0050 | HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1 | RET, IVS1, C-T, +9.7 KB ({dbSNP rs2435357}) | rs2435357 | rs2435357 | RCV000014980, RCV000611595, RCV000627056, RCV001515285, RCV004717904 |
| .0051 | THYROID CARCINOMA, FAMILIAL MEDULLARY | RET, ARG912PRO | rs78347871 | rs78347871 | RCV000014981, RCV000021883, RCV002433464 |
| .0052 | HIRSCHSPRUNG DISEASE, PROTECTION AGAINST | RET, 128496T-C | rs3026785 | rs3026785 | RCV000014982, RCV000288793, RCV000328614, RCV000350648, RCV000380866, RCV000662849, RCV001723569 |
| .0053 | RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE | RET, VAL778ILE | rs75686697 | rs75686697 | RCV000014983, RCV000206045, RCV000562190, RCV001105833, RCV001105834, RCV001108067 |
| .0054 | RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE | RET, PRO198THR | rs76736111 | - | RCV000014984 |
Dear OMIM User,
To ensure long-term funding for the OMIM project, we have diversified our revenue stream. We are determined to keep this website freely accessible. Unfortunately, it is not free to produce. Expert curators review the literature and organize it to facilitate your work. Over 90% of the OMIM's operating expenses go to salary support for MD and PhD science writers and biocurators. Please join your colleagues by making a donation now and again in the future. Donations are an important component of our efforts to ensure long-term funding to provide you the information that you need at your fingertips.
Thank you in advance for your generous support,
Ada Hamosh, MD, MPH
Scientific Director, OMIM